Essen transition model for neuromuscular diseases.

Duchenne muscular dystrophy Interdisciplinarity Juvenile myasthenia gravis Late-onset Pompe disease Neuromuscular diseases The concept of care Transition

Journal

Neurological research and practice
ISSN: 2524-3489
Titre abrégé: Neurol Res Pract
Pays: England
ID NLM: 101767802

Informations de publication

Date de publication:
05 Sep 2022
Historique:
received: 29 04 2022
accepted: 19 07 2022
entrez: 4 9 2022
pubmed: 5 9 2022
medline: 5 9 2022
Statut: epublish

Résumé

With the optimization of medical care structures and the rapid progress in the development of new therapeutic methods, an increase in life expectancy is observed in patients with neuromuscular diseases. This leads to an expansion of the phenotypic spectrum, whereby new or previously less relevant disease manifestations in different organ systems gain more importance. The care of adolescents and young adults with neuromuscular diseases, therefore, requires increasingly close interdisciplinary collaboration within neuromuscular centers. How can the transition process from pediatric to adult care be structured so that the individual disciplines are efficiently integrated into the complex treatment and care process, and the patients' quality of life is improved? A structured transition process was established at the University Hospital in Essen, Germany. Exemplarily, a comparable care concept was developed based on Pompe disease, Duchenne muscular dystrophy, and juvenile myasthenia gravis comprising four elements: (1) With the introduction of cross-department standard operating procedures, the logistical processes, as well as the diagnostic and therapeutic measures, are uniformly coordinated, and the transition process is bindingly defined. (2) To ensure a seamless transition, young patients are seen with their parents during joint consultations before they reach their 17th birthday. This creates an opportunity for patients to get to know the subsequent department structure and build a lasting relationship of trust. (3) A quarterly "transition board" regularly brings together the participating disciplines from pediatric and adult care systems for a case-related interdisciplinary exchange and continuous optimization of the transition process. (4) A cross-department "Transition Database", in which medical findings and parameters are recorded, was implemented as a common information platform and database. The Essen Transition Model aims to close the gap in care for young patients with neuromuscular diseases during the critical transition from pediatric to adult medicine and to create a successful continuation of treatment in adulthood.

Sections du résumé

BACKGROUND BACKGROUND
With the optimization of medical care structures and the rapid progress in the development of new therapeutic methods, an increase in life expectancy is observed in patients with neuromuscular diseases. This leads to an expansion of the phenotypic spectrum, whereby new or previously less relevant disease manifestations in different organ systems gain more importance. The care of adolescents and young adults with neuromuscular diseases, therefore, requires increasingly close interdisciplinary collaboration within neuromuscular centers.
RESEARCH QUESTION OBJECTIVE
How can the transition process from pediatric to adult care be structured so that the individual disciplines are efficiently integrated into the complex treatment and care process, and the patients' quality of life is improved?
MATERIAL AND METHODS METHODS
A structured transition process was established at the University Hospital in Essen, Germany. Exemplarily, a comparable care concept was developed based on Pompe disease, Duchenne muscular dystrophy, and juvenile myasthenia gravis comprising four elements: (1) With the introduction of cross-department standard operating procedures, the logistical processes, as well as the diagnostic and therapeutic measures, are uniformly coordinated, and the transition process is bindingly defined. (2) To ensure a seamless transition, young patients are seen with their parents during joint consultations before they reach their 17th birthday. This creates an opportunity for patients to get to know the subsequent department structure and build a lasting relationship of trust. (3) A quarterly "transition board" regularly brings together the participating disciplines from pediatric and adult care systems for a case-related interdisciplinary exchange and continuous optimization of the transition process. (4) A cross-department "Transition Database", in which medical findings and parameters are recorded, was implemented as a common information platform and database.
CONCLUSION CONCLUSIONS
The Essen Transition Model aims to close the gap in care for young patients with neuromuscular diseases during the critical transition from pediatric to adult medicine and to create a successful continuation of treatment in adulthood.

Identifiants

pubmed: 36058951
doi: 10.1186/s42466-022-00206-8
pii: 10.1186/s42466-022-00206-8
pmc: PMC9442978
doi:

Types de publication

Journal Article

Langues

eng

Pagination

41

Informations de copyright

© 2022. The Author(s).

Références

Arch Dis Child. 2015 Jun;100(6):559-64
pubmed: 25688098
Pediatr Diabetes. 2018 Apr 25;:
pubmed: 29691964
Lancet Neurol. 2018 May;17(5):445-455
pubmed: 29398641
Curr Opin Pediatr. 2001 Aug;13(4):310-6
pubmed: 11717554
Can J Diabetes. 2015 Dec;39(6):520-8
pubmed: 26498219
Pediatr Nephrol. 2015 Apr;30(4):567-76
pubmed: 24890339
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Jun;51(6):592-601
pubmed: 18465101
Pediatrics. 2009 Feb;123(2):417-23
pubmed: 19171604
Pediatrics. 2011 Jul;128(1):182-200
pubmed: 21708806
J Adolesc Health. 1993 Nov;14(7):570-6
pubmed: 8312295
Lancet Neurol. 2018 Apr;17(4):347-361
pubmed: 29395990
Diabetes Care. 2008 Aug;31(8):1529-30
pubmed: 18458141
Nervenarzt. 2018 Oct;89(10):1123-1130
pubmed: 30120487
BMJ Open. 2017 Jun 12;7(6):e015593
pubmed: 28606904
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Apr;55(4):558-67
pubmed: 22441526

Auteurs

Michael Fleischer (M)

Department of Neurology and Center for Translational Neuro- and Behavioral Science, University Medicine Essen, Hufelandstraße 55, 45147, Essen, Germany.

Bayram Coskun (B)

Department of Neurology and Center for Translational Neuro- and Behavioral Science, University Medicine Essen, Hufelandstraße 55, 45147, Essen, Germany.

Benjamin Stolte (B)

Department of Neurology and Center for Translational Neuro- and Behavioral Science, University Medicine Essen, Hufelandstraße 55, 45147, Essen, Germany.

Adela Della-Marina (A)

Division of Neuropediatrics, Department of Pediatrics 1, University Medicine Essen, Essen, Germany.

Heike Kölbel (H)

Division of Neuropediatrics, Department of Pediatrics 1, University Medicine Essen, Essen, Germany.

Hildegard Lax (H)

Institute of Medical Informatics, Biometrics, and Epidemiology, University Hospital Essen, Essen, Germany.
Center for Clinical Trials, University Medicine Essen, Essen, Germany.

Michael Nonnemacher (M)

Institute of Medical Informatics, Biometrics, and Epidemiology, University Hospital Essen, Essen, Germany.
Center for Clinical Trials, University Medicine Essen, Essen, Germany.

Christoph Kleinschnitz (C)

Department of Neurology and Center for Translational Neuro- and Behavioral Science, University Medicine Essen, Hufelandstraße 55, 45147, Essen, Germany.

Ulrike Schara-Schmidt (U)

Division of Neuropediatrics, Department of Pediatrics 1, University Medicine Essen, Essen, Germany.

Tim Hagenacker (T)

Department of Neurology and Center for Translational Neuro- and Behavioral Science, University Medicine Essen, Hufelandstraße 55, 45147, Essen, Germany. tim.hagenacker@uk-essen.de.

Classifications MeSH